Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Lung Neoplasms × Lead × Clear all

Phase

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 2 Thrombophilia 1 Rectal Neoplasms 1 Lung Neoplasms 1 Head and Neck Neoplasms 1 Gastrointestinal Stromal Tumors 1 EGFR-Mutant Lung Cancer 1 Deglutition Disorders 1 Communication Disorders 1 Colorectal Neoplasms 1 Central Nervous System Neoplasms 1 Carcinoma, Pancreatic Ductal 1 Carcinoma 1 Brain Neoplasms 1 Blood Coagulation Disorders 1 Adenocarcinoma 1

Interventions

Carboplatin 143 Radiotherapy 107 Paclitaxel 104 Cisplatin 95 Docetaxel 78 Gemcitabine 72 Pemetrexed 68 Erlotinib Hydrochloride 65 Bevacizumab 42 Etoposide 35 pembrolizumab 29 Vinorelbine 29 Topotecan 28 Gefitinib 24 Irinotecan 23 Surveys and Questionnaires 21 Magnetic Resonance Spectroscopy 18 Radiosurgery 17 Nivolumab 17 Drug Therapy 17 durvalumab 15 Cetuximab 15 Cyclophosphamide 14 Celecoxib 14 Immunohistochemistry 13 Gene Expression Profiling 13 Filgrastim 13 Early Intervention, Educational 13 sargramostim 12 Surgical Procedures, Operative 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00532155 2025-09-10

VITAL

Sanofi

Phase 3 Completed

913 enrolled 16 charts

Carcinoma, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡